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Repeated cycles of oxidative injury by allylamine in vivo induce a proliferative rat vascular (aortic) smooth muscle cell (vSMC)
phenotype characterized by matrix-dependent enhancement of mitogenic sensitivity, changes in cell surface integrin expression,
and osteopontin (opn) overexpression. Here, we show that constitutive and mitogen-stimulated NF-κB DNA binding activity is
enhanced in allylamine vSMCs. Matrix-speciﬁc changes in cellular Rel protein expression were observed in allylamine vSMCs.
The NF-κB DNA binding element located at −1943 in the 5 -UTR strongly inhibited opn promoter activity in allylamine vSMCs,
and this response was regulated by the extracellular matrix. Constitutive increases in opn promoter activity were only seen when
allylamine cells were seeded on a ﬁbronectin substrate, and this response was independent of the NF-κB DNA binding sequence
within the regulatory region. Thus, NF-κB functions as a critical regulator of the allylamine-induced proliferative phenotype in
vSMCs.
1.Introduction
Atherosclerosis is a chronic inﬂammatory disease associated
with thickening of the arterial wall and reduction in vessel
lumen size. The atherosclerotic lesion consists of a mixture
of immune cells, extracellular matrix, fatty deposits, and
phenotypically modiﬁed vSMCs [1]. Injury of vSMCs pro-
duces atherogenic (i.e., activated) phenotypes characterized
by increased proliferative and migratory activities and loss of
diﬀerentiation [2]. These characteristics are replicated when
blood vessels are subjected to viral, chemical, or physical
injury in vivo [3–5], or when vSMCs are cultured in the pres-
ence of mitogens [6], or seeded at low densities on a growth-
permissive ﬁbronectin matrix [7] .T h en a t u r ea n de x t e n to f
phenotypicmodulationissubjecttoregulationsincevariable
degrees of phenotypic drift are seen depending upon the
nature of the stimulus and the culture conditions in vitro [8].
The ﬁnding that vSMCs isolated from atherosclerotic vessels
express characteristics of the activated phenotype suggests
that the atherosclerotic process involves reprogramming
of vascular gene expression. This is comparable to the
changes seen in vSMCs isolated from animals challenged
chronically with allylamine (CH2=CHCH2NH2) ,ap r i m a r y
amine metabolized within the vascular compartment to
acrolein and hydrogen peroxide [9].
Repeated exposure of rats to allylamine induces vascular
lesions of atherosclerotic morphology that arise from the
injurycausedbyacroleinandhydrogenperoxide,byproducts
of oxidative deamination within the vascular wall [10].
vSMCs are enriched in a copper-containing amine oxidase
that catalyzes the metabolism of allylamine and mediates
depletion of cellular glutathione, direct oxidant injury to the
tunica media, and phenotypic modulation of vSMCs to less
diﬀerentiatedphenotypes.In vitro analysisofvSMCsisolated
from allylamine-treated animals revealed disorganization of
the contractile apparatus, increases in endoplasmic reticu-
lum, and emergence of a prominent nucleolus [11]. These
activated vSMCs acquire a signiﬁcant proliferative advantage2 Oxidative Medicine and Cellular Longevity
over vSMCs from control counterparts and exhibit enhanced
phosphoinositide-3-kinase (PI-3-K) activity, secretion, and
deposition of matrix proteins, and modulation of integrin-
coupled NF-κB signaling [12].
NF-κB is a dimeric transcription factor that resides in
the cytoplasm in association with an inhibitory protein,
IκB. The dimer consists of members of the Rel protein
family including RelA/p65, RelB, c-Rel, p50, and p52. In
response to a positive stimulus, IκB is phosphorylated by I-
κ-kinase (IKK). Phosphorylation of IκB renders the protein
susceptible to ubiquitination and proteolysis, allowing the
NF-κB dimer to translocate to the nucleus and bind cis-
acting regulatory sequences [13]. The ability of NF-κB
to activate or repress target genes also depends on the
phosphorylation status of Rel proteins [14]. NF-κB dimers
of varying composition bind preferentially to distinct DNA
sequences thus providing another point for diﬀerential
regulation [15]. NF-κB regulates genes involved in the
inﬂammatory,mitogenic,andapoptoticresponse.Ofinterest
is opn, a cytokine with prominent roles in immunity,
bone remodeling, cancer, multiple sclerosis, arthritis, kidney
dysfunction, and atherosclerosis. opn is sequestered in the
extracellular matrix of atherosclerotic plaques and binds to
αVβ1,αVβ3, αVβ5,a n dα9β1 integrin receptors on vSMCs
[16,17]tomodulateproliferation,migration,andexpression
of inﬂammatory cytokines. The opn gene is regulated by
upstream stimulatory factor 1 (USF1) and activator protein-
1 (AP-1) transcription factors [18], but to date a deﬁnitive
role for NF-κB has not been described. Detailed correlations
between opn and atherosclerosis in humans [19, 20], and in
animal models, have been reported [21].
We have previously described a central role for integrin-
extracellular matrix signaling in vSMC proliferation [12].
Evidence is presented here that extracellular matrix- and
DNA sequence-speciﬁc changes in NF-κB activity regulate
opn promoter activity. These data indicate that NF-κBp a r -
ticipates in the regulation of vSMC phenotypes by oxidative
chemical injury.
2.MaterialsandMethods
2.1. Materials. Allylamine (99% pure) was purchased from
Aldrich (Milwaukee, WI). Medium 199, trypsin, and
antibiotic/antimycotic solution were purchased from Gibco
(Grand Island, NY). [32P]-ATP was purchased from NEN
Radiochemicals (Grand Island, NY). NF-κBc o n s e n s u s
oligonucleotide and T4 polynucleotide kinase were pur-
chased from Promega (Madison, WI). Antibodies for Rel
proteins, IκBα,I κBβ, and IKK were purchased from Santa
Cruz Biotechnologies (Santa Cruz, CA). The antibody
for phosphoserine was obtained from Zymed Laboratories
Inc. (San Francisco, CA). Protein A-sepharose beads were
obtained from Amersham Biosciences (Piscataway, NJ).
Matrix-coated plates (BioCoat) were purchased from Becton
Dickinson (Franklin Lakes, NJ). Nitrocellulose membranes
were purchased from BioRad (Hercules, CA). Dura chemi-
luminescent substrate was purchased from Pierce (Rockford,
IL). Kits for plasmid and RNA puriﬁcation and DNase treat-
ment were from Qiagen (Valencia, CA). The QuikChange
Site-Directed Mutagenesis kit was from Stratagene (La Jolla,
CA). Fugene 6 was from Roche (Indianapolis, IN). All other
chemicals were purchased from Sigma Chemical Co. (St.
Louis, MO).
2.2. Cell Culture. vSMCs were isolated by enzymatic diges-
tion of aortas from 12 adult male Sprague-Dawley rats gav-
aged with allylamine (70mg/kg) or 12 control rats gavaged
with tap water for 20 days as described in detail previously
[8]. Subcultures were prepared by trypsinization of primary
cultures and maintained in Medium 199 supplemented with
10% FBS and 2mmol/L L-glutamine in 5% CO2 :95% air at
37◦C. G0 synchronization was accomplished by incubation
of cell cultures for 72 hours in Medium 199 containing 0.1%
F B Sa sd e s c r i b e d .
2.3. Electrophoretic Mobility Shift Assay (EMSA). Nuclear
extracts were prepared using standard methodologies, quick
frozen in liquid nitrogen, and stored at −80◦C. For EMSA,
5μg of nuclear protein was incubated with [32P]-end-labeled
NF-κB consensus oligonucleotide for 1 hour. End labeling
of oligonucleotides was performed with T4 polynucleotide
kinase and γ[32P] ATP. Binding reactions were performed
in 0.25x HEGDK (25mmol/L HEPES pH 7.6, 1.5mmol/L
EDTA, 10% glycerol, 1mmol/L DTT, 0.5mol/L KCl) buﬀer
supplemented with 1mmol/L DTT, 20μg BSA, and 50ng
poly-dIdC. After addition of loading dyes, reactions were
electrophoresed on 7% nondenaturing polyacrylamide gels
at 25mA in 0.5x TBE (0.045mol/L Tris, 0.045mol/L Boric
acid, 0.001mol/L EDTA). Gels were dried and exposed
to Kodak X-OMAT ﬁlm with an intensifying screen for
autoradiography at −80◦C for 48 hours.
2.4. SDS-PAGE and Western Blotting. Subconﬂuent cul-
tures were rinsed with PBS and scraped. The pellet was
resuspended with RIPA buﬀer (50mmol/L Tris pH 7.4,
150mmol/L NaCl, 1% NP-40, 10% sodium deoxycholate,
1mg/mL leupeptin, 1mg/mL aprotinin, 1mg/mL pepstatin)
a n ds t o r e da t−20◦C. Three-10μg of protein were diluted in
sample buﬀer, boiled for 5 minutes, and loaded into a 7%
denaturing polyacrylamide gel. Electrophoresis proceeded
at 18–22mA until tracking dyes reached the bottom. The
gels were equilibrated in transfer buﬀer for 5 minutes and
then transferred to nitrocellulose membranes for 9 hours
at 20V at 4◦C. Membranes were blocked in 5% milk in
TBS (0.1mol/L Tris pH 7.5, 0.15mol/L NaCl) with 0.1%
Tween (TTBS) for 18 hours then probed overnight with a
1:1000 dilution of rabbit primary antibody. After 6 × 5min
washes in TTBS, membranes were incubated for 4hr with
a 1:25000 dilution of goat anti-rabbit IgG conjugated to
horseradish peroxidase (HRP). Following another series of
washes, membranes were incubated for 5 minutes in a 1:2
dilution of chemiluminescent substrate and then visualized
for 30 seconds to 2 minutes on Kodak X-OMAT ﬁlm.
2.5. Immunoprecipitation. Twenty ﬁve μgo fp r o t e i nw a s
incubated overnight at 4◦Cw i t h1 μg of antibody againstOxidative Medicine and Cellular Longevity 3
IKK. Fifty μL of a 50% slurry in TE (10mmol/L Tris,
1mmol/L EDTA pH 8.0) of protein A-sepharose was added
to each immunoprecipitation reaction, and agitated for
4 hours at room temperature. The sepharose beads were
pelleted and washed three times with TBS. Pellets were
r e s u s p e n d e di nL a e m m l is a m p l eb u ﬀer and boiled for 5
minutes. After sepharose, beads were pelleted, 10μLo f
supernatant was loaded for SDS-PAGE.
2.6. Synthetic Oligonucleotides. Following examination of
published sequences for mouse c-Ha-ras promoter, rat opn
promoter, and rat matrix metalloproteinase-9, oligonu-
cleotides corresponding to NF-κB binding domains in
these promoters were synthesized. The Genbank accession
numbers and sequences used for each are shown in Table 1.
2.7. Generation of opn Promoter Constructs. The full-length
rat opn promoter was provided by Dr. A. Ridall (UT Health
Science Center, Houston, TX). 2094 base pairs were ligated
into pGL2-basic using NheI and XhoI restrictions sites. This
construct was dubbed 2094 rOPNpr and sequential deletions
generated beginning at 1157 (1157 rOPNpr), 672 (672
rOPNpr), and 127 (127 rOPNpr), respectively. MatInspector
v2.2 (available at http://www.generegulation.de/) identiﬁed
a vitamin D response element (VDRE), as well as AP-1,
NF-κB, and USF1 transcription factor binding sites within
the promoter. Site-directed mutagenesis of each of these
sites was performed using Stratagene’s QuikChange Kit
per manufacturer’s speciﬁcations. Following high-ﬁdelity
PCR, the template was digested with DpnI endonuclease to
cleave methylated DNA and multiple clones sequenced for
veriﬁcation of mutations (Table 2).
2.8. Transfections. vSMCs were seeded at a density of 4×104
cells per well in a 12-well plate and allowed to recover for
8h before transfection with luciferase constructs and a β-
gal-expressing plasmid at a ratio of 1.5:1.0μg. Plasmids
were mixed at a ratio of 6μLt o1 μgD N Ai ns e r u m - f r e e
Medium 199 and added to the cultures for 36h. Wells
were rinsed with PBS and harvested using a lysis buﬀer
includedinTropix’sGalacto-LightReporterAssayKit(Foster
City, CA). Lysates were frozen until analysis. Twenty-ﬁve μL
of lysate was pipetted into two 96-well plates and either
combined with 80μL of a luciferin working solution to
measure luminescence in a BMG’s Fluostar OPTIMA plate
reader, or 70μL of Tropix’s β-gal reagent. β-gal samples were
incubatedfor1hrbeforetheadditionof100μLofaccelerator
solution for measurement using an OPTIMA plate reader.
2.9. Statistics. All other statistical relationships were exam-
ined by ANOVA and Fisher’s least signiﬁcant diﬀerence,
unless otherwise noted. Statistical signiﬁcance was assigned
at the P<0.05 level.
3. Results
Repeated cycles of oxidative injury by allylamine induce
a proliferative vSMC phenotype [11, 12]. To evaluate the
Table 1
Mouse H-ras 5  GGG GGT GGG GTC CTC CCT TTT 3 
(AF268311) 3  CCC CCA CCC CAG GAG GGA AAA 5 
Rat opn 5  GAT TTG TGG AAT TTC CCT GCA 3 
(AF017274) 3  C T AA A CA C CT T AA A GG G AC G T5  
Rat MMP-9 5  GGG GTT AGG GGG TTC CCCG T G3  
(AJ428366) 3  CCC CAA TCC CCC AAG GGG CAC 5 
stability of the activated vSMC phenotype induced by
allylamine, the proliferation rates of control and allylamine
cells during serial propagation in vitro were compared in
cultures seeded at equal densities. Signiﬁcant diﬀerences
in proliferation were seen in both primary and secondary
cultures of vSMCs isolated from allylamine-treated animals
compared to controls (Figure 1). The proliferative vSMC
phenotype induced by allylamine was sustained for up to
25 passages in serial culture. The proliferation of vSMCs of
control and allylamine cells in primary culture was more
restricted than in cultures during the 3rd and 25th passage.
Thisdiﬀerencemaybeaccountedforbytheselectionofmore
proliferative phenotypes during cell culture or partial shifts
toward proliferative phenotypes.
The proliferative phenotype induced by allylamine is
characterized by enhanced secretion and deposition of
matrix proteins, and modulation of integrin-coupled NF-κB
signaling[12].ToevaluatetheroleofNF-κBintheregulation
of the proliferative allylamine phenotype, experiments were
conducted to examine a time course of NF-κB binding activ-
ity to a consensus sequence in quiescent vSMC subcultures
following mitogenic stimulation. Cells were synchronized
by serum restriction and stimulated into growth with 10%
serum for up to 5 hours. The proﬁle of NF-κB binding
activity in allylamine-modiﬁed vSMCs was diﬀerent from
control counterparts, with 3 distinct complexes detected at
diﬀerent times (Figure 2(a)). Constitutive NF-κβ binding
activitywasenhancedinallylamine-modiﬁedvSMCsrelative
to controls. Mitogenic stimulation induced DNA binding
activity as early as 0.5hr in both cell types, but the predom-
inance of individual complexes over time was phenotype-
speciﬁc. Increased DNA binding activity was observed at all
times in allylamine cells.
Because nuclear translocation of NF-κB is known to
be dependent upon the degradation of IκB proteins [13],
experiments were conducted next to evaluate steady-state
levels of IκBα and IκBβ across the full synchronization
and cell cycle transition regimen. The relative abundance
of IκBs was not aﬀected by growth factor deprivation since
comparable protein levels were detected in synchronized
cultures, as well as 0.5 hours after mitogen addition
(Figure 2(b)). Degradation of IκBα was observed in the
activated vSMC phenotype within 1hr of serum stimulation,
a response that peaked by 2hr and began to subside by
3hr. Modest reductions in IκBα were observed in control
vSMCs, showing that early activation of NF-κBi nr e s p o n s e
to mitogenic stimulation is a characteristic feature of the
allylamine phenotype (Figure 2(b)). No degradation of IκBβ
was observed in either cell type at any of the time points4 Oxidative Medicine and Cellular Longevity
Table 2: Site-directed mutagenesis of opn promoter constructs.
Binding site Sequence
VDRE Original 5  CCTGGAAGGGTCATATGGTTCAGCTCCGAGG 3 
Mutated 5  CCTGGAAtcGTtcTATGGaTCtGCTCCGAGG 3 
AP-1 Original 5  TCGTGTTGAGTCATTCCTGTGGGC 3 
Mutated 5  TCGTGTTacaTCATTCCTGTGGGC 3 
NF-κB Original 5  AGGATTTGTGGAATTTCCCTGCACAGC 3 
Mutated 5  AGGATTTGaaGAATaaCaCTGCACAGC 3 
USF1 Original 5  AAACAAACTCATGTGGGTGTCGTGCTT 3 
Mutated 5  AAACAAACTCAaaTGGGTGTCGTGCTT 3 
Transcription factor binding sites were mutated using Stratagene’s QuikChange and Site-Directed Mutagenesis Kit. Binding sites are underlined, and mutated
bases shown in lowercase.
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Figure 1: Stability of the allylamine-activated vascular smooth
muscle cell phenotype during serial propagation in vitro.V a s c u l a r
smooth muscle cells were isolated from control and allylamine-
treated rats and established in primary culture or passaged for up
to 25 passages using established procedures. Cells were seeded at
a density of 150cells/mm2 and incubated with 10% fetal bovine
serum for four days in culture. The results shown represent the
average number of cells in 5–7 replicate dishes during primary
culture or at passages 3 and 25 for the two cell types. Similar
patterns were observed in 3 separate experiments. The results show
that allylamine cells exhibited a proliferative advantage that was
sustained for multiple passages in vitro.
examined. The degradation of IκB proteins is preceded
by phosphorylation by the IκB kinases, IKKα and IKKβ
[13]. Analysis of immunoprecipitated IKK in cells seeded
on a plastic substrate revealed slightly increased serine
phosphorylation in allylamine-modiﬁed vSMCs irrespective
of growth status (Figure 2(c)). Two immunoreactive bands
weredetected,indicatingrecognitionofbothIKKαandIKKβ
isoforms (not shown).
We have previously demonstrated that NF-κBD N A
binding activity is diﬀerentially modiﬁed by the extracellular
matrix [22]. To evaluate the possibility that ECM-dependent
changes in NF-κB DNA binding activity were related to
Rel protein expression, control and allylamine-modiﬁed
vSMCs were seeded on plastic, collagen I, or ﬁbronectin,
and protein expression was determined by SDS-PAGE and
Western blotting (Figure 3). The abundance of RelA/p65
was inﬂuenced by matrix and cellular phenotype, with
reductions in band intensity observed in allylamine cells
seeded on plastic or ﬁbronectin, but not collagen I. A second
immunoreactive band at approximately 45kDa was detected
exclusively in allylamine-modiﬁed vSMCs on all matrices,
with signal intensity being most prominent on plastic. The
levels of RelB protein were slightly lower in allylamine cells
seeded on all substrates, and as with p65, this reduction
was most pronounced on plastic. c-Rel and p52 expression
increased in allylamine cells seeded on plastic or collagen
I but decreased slightly on ﬁbronectin. In contrast, p50
expression was elevated in allylamine cells seeded on plastic
orcollagenIbutremainedunchangedwhencellswereseeded
on ﬁbronectin.
Phenotype-speciﬁc changes in the prevalence of Rel
proteins may translate into variable composition of NF-κB
dimers. Such alterations may inﬂuence the proﬁle of tran-
scriptional regulation since diﬀerent dimers may prefer-
entially recognize diﬀe r e n tt a r g e ts e q u e n c e s .T ot e s tt h i s
concept, NF-κB binding elements from four diﬀerent pro-
moters were used to evaluate binding activity in nuclear
extracts from control and allylamine vSMCs seeded on
plastic. Up to four major binding protein complexes could
be identiﬁed, two of which were conserved across all of
the NF-κB binding sequences examined (Figure 4). With the
exception of proteins bound to the NF-κBs e q u e n c ef r o m
theratmatrixmetalloproteinase-9(MMP-9)promoter,band
intensities were higher in nuclear extracts from allylamine-
activated vSMCs compared to controls, indicating a higher
degree of NF-κB activation. The intensity of the two faster-
mobility complexes (C3 and C4) was sequence speciﬁc, with
strong binding observed to the NF-κB consensus and c-Ha-
ras sequences.
Enhanced expression of opn mRNA and protein char-
acterizes the allylamine phenotype [23]. Because increased
NF-κB binding to the opn promoter may contribute to
diﬀerential gene regulation, experiments were conducted
next to evaluate opn promoter activity in control and ally-
lamine vSMCs. A schematic for serial deletions is shown in
Figure 5(a). Activation of luciferase reporter constructs was
observed in both cell types, with considerably higher activ-
ities seen upon progressive deletion of upstream sequences
down to 572bp (Figure 5(b)). Thus, inhibitory sequences
located between (2094 and 1157) and (1157 and 672) appearOxidative Medicine and Cellular Longevity 5
Control
Allylamine
hours
Mitogenic stimulation
fp
Growth arrest
C1
C2
C3
C3
C1
C2
12345 0.5 0 −24 −48 −72
(a)
CACA CACA CA CA
12 3
Synchronization
hours
Mitogenic stimulation
IκBα
IκBβ
0.5 −24 −48
(b)
Synchronized Released
CC AA
CC AA
0
0.2
0.4
0.6
0.8
1
1.2
p
h
o
s
p
h
o
s
e
r
i
n
e
/
I
K
K
B
a
n
d
 
i
n
t
e
n
s
i
t
y
(c)
Figure 2: Activation of NF-κB signaling in allylamine cells. Panel (a) shows NF-κB binding activity in control and allylamine cells over the
course of a synchronization and mitogenic stimulation cycle. Cells were seeded at equivalent densities on plastic tissue culture dishes and
nuclear extracts collected at multiple time points as noted. EMSA were performed using end-labeled NF-κB consensus oligonucleotide as a
probe. Arrows denote the major NF-κB binding complexes identiﬁed. Similar results were seen in 2 independent experiments. C# denotes
individual complexes. Panel (b) shows IκBα and IκBβ protein levels in control and allylamine cells over the course of a synchronization and
mitogenic stimulation cycle. Cells were seeded at equivalent densities and serum restricted for 72hr to synchronize in G0, and then released
into growth by the addition of 10% fetal bovine serum. Crude protein extracts were harvested at various times after addition of complete
medium. Protein extracts were electrophoresed, electroblotted onto nitrocellulose, and probed for each IκB. Similar results were observed
in 3 separate experiments. C: control; A: allylamine. Panel (c) shows serine phosphorylation levels of immunoprecipitated IKKα and IKKβ
in control and allylamine cells. Immunoprecipitated IKKα/β was electrophoresed and transferred onto two nitrocellulose membranes and
blocked overnight in 5% milk. One membrane was probed for IKKα/β, and the other for phosphoserine, followed by incubation with
horseradish peroxidase- (HRP-) labeled secondary. Membranes were then incubated with chemiluminescent substrate and visualized using
the KODAK Image Station. Densitometry was performed using Kodak 1D Image Software. : control, : allylamine.
to signiﬁcantly repress promoter activity in control and
allylamine vSMCs. Promoter activity was completely lost in
the minimal −127 promoter construct, and in all instances,
promoter activity was considerably lower in allylamine cells
compared to controls.
Examination of sequences between −2094 and −1157
revealed putative cis-acting elements for AP-1, NF-κBa n d
USF, as well as the well-characterized VDRE. To evaluate
the relative contribution of these elements, the inducibility
of mutant promoter constructs generated by site-directed
mutagenesis was examined (Figure 5(c)). In control cells,
disruption of any one of the elements signiﬁcantly reduced
luciferase activity (Figure 5(d)), implicating these elements
in positive regulation of opn promoter activity. Interestingly,
in allylamine cells only mutation of the VDRE reduced
promoter activity, while mutation of AP-1 was inert, and
mutation of NF-κB and USF binding sites returned tran-
scriptional activity to full-length control levels. These results
suggestthattheopnpromoterisundernegativeregulationby
NF-κBa n dU S F .
Lastly, the inﬂuence of a collagen I or ﬁbronectin matrix
on opn promoter activity was examined. The pattern of opn
promoter activity was inﬂuenced by the matrix on which the
cells were seeded with no changes seen between allylamine
and control cells when cells were seeded on collagen (a
nonpermissive matrix), and marked increases in allylamine
cells over control cells when cells were seeded on ﬁbronectin
(a proliferation-permissive matrix), Figure 6(a).D e l e t i o no f
the NF-κB binding site slightly decreased promoter activity
in control cells but increased promoter activity in allylamine
cells seeded on collagen I. The positive regulatory inﬂuence
of ﬁbronectin on opn promoter activity was not inﬂuenced
by mutation of the NF-κB binding site (Figure 6(b)).
4. Discussion
Allylamine injury induces vascular lesions in the rat aorta
that resemble those seen in atherosclerotic vessels [24].
This response involves accumulation of oxidative byproducts6 Oxidative Medicine and Cellular Longevity
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Figure 3: Expression of Rel proteins in control and allylamine
cells seeded on plastic, collagen I, ﬁbronectin, and laminin. Protein
extracts from cells at 80% conﬂuence were electrophoresed in a
7% denaturing polyacrylamide gel, transferred onto nitrocellulose,
and blocked overnight in 5% milk in TBS with 0.1% Tween.
Membranes were probed overnight followed by incubation with
horseradish peroxidase-labeled secondary antibody for 4 hours
and then incubated with 1:2 chemiluminescent substrate: TTBS
for 5 minutes, followed by visualization through autoradiography.
Similar results were seen in three separate experiments. C: control;
A: allylamine.
Ha-ras rOPN rMMP-9 Promega
fp CAfp CA fp CAfp CA
C1
C2
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C4
Figure 4: DNA binding activity in control and allylamine vSMCs
to a panel of NFκB binding sequences. Nuclear extracts were
subjected to EMSA against NF-κB binding domains from several
promoters (Ha-ras, rOPN, and rMMP-9), as well as a consensus
oligo (Promega). Gels were dried and exposed to ﬁlm for 48 hours
at −80◦C with intensifying screen. Arrows denote major NF-κB
binding complexes identiﬁed. C: control; a: allylamine. Similar
results were seen in multiple experiments.
within the vascular compartment, depletion of cellular
glutathione, and activation of redox signaling [10, 25, 26].
The activated aortic vSMC phenotype induced by allylamine
is stable suggesting that reprogramming of proliferative
control contributes to phenotypic transition. Genomic
reprogramming in vSMCs isolated from allylamine-injured
vessels may involve alterations in NF-κB signaling since
NF-κB DNA protein binding is markedly enhanced. These
ﬁndings parallel the molecular alterations seen in vSMCs
isolated from atherosclerotic lesions [27, 28], and during the
chronic hyperproliferative response to inﬂammation [28].
The present studies detail the molecular basis of NF-κB
dysregulation in allylamine vSMCs.
Disruption and remodeling of the vessel wall matrix
is a pivotal process in atherogenesis where expression of
activated vSMC phenotypes correlates with disruption of
the basal lamina by macrophage metalloproteinases [29]. As
the process of phenotypic modulation progresses, activated
vSMCs change the relative composition of the extracellular
matrix [30]. Collagen I becomes a large component of the
matrix [31], as does ﬁbronectin, a protein which promotes
dediﬀerentiation of vSMCs within the lesion [32]. Previous
data from this laboratory indicate that collagen I restricts
the ability of allylamine-activated cells to proliferate, while
cells seeded on plastic or ﬁbronectin continue to grow
at faster rates than controls [22]. Collagen I may elicit a
r e d u c t i o ni np r o l i f e r a t i v ea c t i v i t yt h r o u g hc h a n g e si np 2 1
and cyclin D1 expression [33], while ﬁbronectin mediates
increases in cellular proliferation. The underlying mecha-
nismsthattranslatereciprocalinteractionsbetweenintegrins
andextracellularmatrixproteinstotranscriptionalresponses
remain to be fully elucidated. In healthy vessels, matrix
interactions protect against hyperproliferation of vSMCs,
while in injured vessels, as the composition of the matrix
changes, integrin-coupled NF-κB activation and function is
subject to signiﬁcant modulation.
Matrix-dependent alterations in Rel protein expression
were noted in allylamine vSMCs compared to controls,
suggesting that NF-κB dimers in allylamine vSMCs at any
given point diﬀer from those in controls. Because each dimer
may preferentially interact with a diﬀerent subset of DNA
domains [15], shifts in Rel protein expression may result in
diﬀerential modulation of gene expression. This appears to
be the case since diﬀerences in NF-κB DNA binding activity
were observed for diﬀerent promoters, and opn promoter
activity was diﬀerentially regulated in allylamine cells. Shifts
in dimer prevalence have been described during B-cell
diﬀerentiation leading to altered transcriptional activation of
the immunoglobulin κ light chain [34].
Progressive deletion analysis of the opn promoter uncov-
ered strong repressor sequences within the promoter in
vSMCs irrespective of phenotype. While the cis-acting ele-
ments responsible for gene regulation remain to be ﬁrmly
established, several important ﬁndings were made. Notable
diﬀerences between the two cellular phenotypes include
(1) the activity of the opn promoter in allylamine cells
was considerably lower than in control cells; (2) mutation
of NF-κB, AP-1, USF-1, and VDRE elements signiﬁcantly
reducedluciferaseactivityincontrolcells,whileinallylamine
cells only mutation of VDRE exerted a negative eﬀect;
(3) mutation of NF-κB and USF binding sites in allylamine
cells restored transcriptional activity to full-length control
levels. Together, these ﬁndings suggest that opn promoter
activity in allylamine cells is under negative control, possibly
byNF-κBandUSF-1transcriptionfactors.Infact,deletionof
the NF-κB binding site slightly decreased promoter activity
in control cells seeded on collagen I but did not aﬀect theOxidative Medicine and Cellular Longevity 7
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Figure 5: Proﬁles of osteopontin promoter activity in control and allylamine-activated vascular smooth muscle cells. Panel (a) shows a
schematic representation of the rat osteopontin promoter, cis-acting elements within the full-length promoter, and several deletions thereof.
Panel (b) shows a comparison of osteopontin promoter activity in control and allylamine cells. Control and allylamine cells were seeded at
equivalent densities and allowed to recover for 8 hours. Cultures were then transfected with the rat osteopontin promoter in pGL2-basic,
a luciferase vector, or a deletion thereof (1157 rOPNpr, 672 rOPNpr, 329 rOPNpr, and 129 rOPNpr). Also included as a control was β-
galactosidase, to allow normalization of luciferase signal. : control, : allylamine. ∗ indicates signiﬁcant diﬀerence from 2094 rOPNpr
in control, + indicates signiﬁcant diﬀerence from 1157 rOPNpr in control, # indicates signiﬁcant diﬀerence from 657 rOPNpr in control
(P<0.05). Panel (c) identiﬁes mutants generated site-directed mutagenesis of the rat osteopontin promoter on activity proﬁles in control
and allylamine cells. Several sites were identiﬁed through computerized examination and mutated using Stratagene’s QuikChange Site-
Directed Mutagenesis Kit. Alterations in each element are denoted by a capital letter. Panel (d) shows osteopontin promoter activity in
control and allylamine cells after site-directed mutagenesis. Control and allylamine cells were seeded at equivalent densities and allowed
to recover for 8 hours. Cultures were transfected with the rat osteopontin promoter (rOPNpr) in a luciferase vector, or a vector in which
a cis-acting element has been mutated through site-directed mutagenesis. These mutants are denoted VDREx rOPNPr, AP-1x rOPNpr,
NF-κBx rOPNpr, USF1x rOPNpr, USF2x rOPNpr, and USF3x rOPNpr. : control, : allylamine. ∗ indicates signiﬁcant diﬀerence from
2094 rOPNpr in control, + indicates signiﬁcant diﬀerence from VDREx rOPNpr in control, # indicates signiﬁcant diﬀerence from NF-κBx
rOPNpr in control (P<0.05). Similar results were seen in two separate experiments.
positive regulatory inﬂuence of ﬁbronectin on promoter
activity, indicating that NF-κB may function as a positive
or negative eﬀector on opn promoter activity depending on
phenotype.
Of note was the ﬁnding that opn promoter activity is
inﬂuenced by the extracellular matrix on which the cells are
seeded, with collagen exerting a repressor eﬀect on promoter
activity, and ﬁbronectin aﬀording a selective advantage to
allylamine cells. This pattern of promoter activity parallels
the proliferation and Rel protein expression proﬁles of
control and allylamine cells, suggesting that the extracellular
matrix dictates patterns of NF-κBa n dopn signaling in
allylamine cells. Thus, signaling through integrin receptors
bound to ﬁbronectin participate in the regulation of opn
promoter activity in allylamine cells. This is consistent with
the upregulation of αVβ3 in allylamine cells seeded on a
permissive matrix [23]. Regulation of opn expression in cells
seeded on ﬁbronectin does not seem to involve the NF-κB
binding site located at −1943, while repression of promoter
activity on collagen I may be partially accomplished through
this NF-κB element. The ability of ﬁbronectin to induce
dediﬀerentiation of vSMCs has been well documented [32,
35], as well as its ability to induce expression of opn in
cultured vSMCs.8 Oxidative Medicine and Cellular Longevity
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Figure 6: Activity of osteopontin promoter-luciferase constructs in control and allylamine cells seeded on diﬀerent matrices. Control and
allylamine cells were seeded at equivalent densities on collagen I, ﬁbronectin, and laminin, and allowed to recover for 8 hours. Cultures
were then transfected with the rat osteopontin promoter (2094 rOPNpr) in a luciferase vector panel (a), and a full length construct in
which the NF-κB site was mutated (NF-κBx rOPNpr) panel (b). These mutants are denoted VDREx rOPNPr, AP-1x rOPNpr, NF-κBx
rOPNpr, USF1x rOPNpr, USF2x rOPNpr, and USF3x rOPNpr. : control, : allylamine; ∗ indicates signiﬁcantly diﬀerent from control, +
indicates signiﬁcantly diﬀerent from 2094 rOPNpr in same cell type on same seeding matrix (P<0.05). Similar results were seen in multiple
experiments.
opn is regarded as a critical modulator of atherogenesis,
but little is known about the regulation of opn promoter
in vSMCs. Interestingly, upstream stimulatory factor (USF1)
has been implicated in injury-induced opn expression [36],
while AP-1 has been implicated in regulation of opn [18],
possibly as a result of increased ERK1/ERK2 activity [37].
Thus, NF-κB may serve as a regulator of the opn promoter
in trans, an eﬀect clearly dependent on the extracellular
matrix. The repressor activity of NF-κB has been linked
to the formation of p50/p52 heterodimers or p50/p50
homodimers [38, 39], a correlation that is consistent with
thehigherlevelsoftheseproteinsobservedinallylaminecells
compared to controls, and the inﬂuence of ﬁbronectin on
patterns of protein expression. Since p50 and p52 contain
no transactivation domain, hetero- and homodimers of
these Rel proteins can bind NF-κB binding sites to inhibit
transactivation [39, 40]. Indeed, a study of NF-κB binding
sites suggests a high aﬃnity of repressive NF-κB dimers
for the opn promoter sequence. Interestingly, cooperation
between USF-1 and NF-κB in the negative regulation of opn
promoteractivityispossiblesincemutationofeitherbinding
site restored promoter activity in allylamine cells to control
levels, and cooperativity between these transcription factors
in binding to nucleosomes has been described [41].
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